Building on the immune-mediated and immunomodulatory functions of IgE we observed in vitro and ex vivo, we demonstrated tumor growth inhibition by Tras IgE in two Tras-resistant models; one with high HER2 (HER2 3+) and one with medium HER2 (HER2 2+) expression levels. Here, IGHE is linked to neoplasm.